(Q45867352)

17 December 2017

title

Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients (English)

1 reference

17 December 2017

1 reference

1 reference

1 reference

Stallwood Y

1

1 reference

17 December 2017

Fisher KD

series ordinal

2

1 reference

17 December 2017

Gallimore PH

series ordinal

3

1 reference

17 December 2017

Mautner V

series ordinal

4

1 reference

17 December 2017

publication date

1 April 2000

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

7

1 reference

17 December 2017

page(s)

637-643

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301152

exact match

0 references

cites work

Adenoviral vectors: not to be sneezed at.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

Development and application of adenoviral vectors for gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

The prognostic implication of ascites in advanced-stage ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

Antipeptide antisera define neutralizing epitopes on the adenovirus hexon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

Cystic fibrosis. Vehicles for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

Immune responses to adenovirus and adeno-associated virus in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

Inhibition of adenovirus-mediated gene transfer by bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

Human adenovirus type 2 protein IIIa. I. Purification and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

7 January 2021

Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

7 January 2021

Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

7 January 2021

Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

7 January 2021

"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

7 January 2021

Circumvention of immunity to the adenovirus major coat protein hexon.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301152

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301152

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017